Literature DB >> 6162061

Specificity of an immunoprecipitin test for non-A non-B hepatitis.

D J Suh, Y White, A L Eddleston, S Amini, K Tsiquaye, A J Zuckerman, R Williams.   

Abstract

An immunodiffusion system detecting an antigen showing immunological identity with international laboratory reference sera was developed by use of acute-phase and recovery sera from patients with transmission-proven non-A, non-B acute hepatitis. In other liver diseases the antigen was also present in a high proportion of patients and there were similar findings in conditions with high levels of circulating immune complexes in the serum. Fractionation of antigen-containing sera by column chromatography, polyethylene glycol treatment, and reduction and alkylation also suggested that immune complexes may be responsible for antigenic activity. The precipitation lines did not develop in the presence of 10 mmol/l EDTA or at a pH less than 8.0 and the reactant in "antibody" containing sera was shown not to be an immunoglobulin. Although the transmission of non-A, non-B hepatitis by blood and blood products shows that viral antigens are likely to be present in the circulation, this study shows that immune reactions apparently closely associated with the infection may be detecting immune complexes rather than specific viral components and emphasises the need for careful evaluation of the specificity of other reported serological tests for non-A, non-B hepatitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6162061     DOI: 10.1016/s0140-6736(81)90059-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  4 in total

1.  Immune response to purified non-A, non-B hepatitis-related antigen demonstrated by leukocyte migration inhibition in patients recovering from the infection.

Authors:  A Nicole; O Spertini; D Lavanchy; P C Frei
Journal:  Infection       Date:  1986 Jan-Feb       Impact factor: 3.553

2.  Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders.

Authors:  M Bamber; A Murray; B A Arborgh; P J Scheuer; P B Kernoff; H C Thomas; S Sherlock
Journal:  Gut       Date:  1981-10       Impact factor: 23.059

3.  Fulminant hepatic failure and artificial liver support.

Authors:  A E Gimson; R Ede; S Braude; R D Hughes; P J Langley; R Williams
Journal:  Gastroenterol Jpn       Date:  1982-04

4.  Detection of non-A, non-B hepatitis antigen by immunocytochemical staining.

Authors:  K H Burk; P E Oefinger; G R Dreesman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.